Articles from Vida Health

Vida Health, a virtual, personalized obesity care provider that helps patients manage obesity and related conditions, today announced the appointment of Jason Macaleer as Chief Strategy Officer and Mike Rolla as Chief Growth Officer. Seasoned healthcare leaders with a combined 40+ years of industry experience, Macaleer and Rolla will partner to help scale the company’s impact amid growing demand for evidence-based obesity and cardiometabolic solutions.

Vida Health, a virtual, personalized obesity care provider that helps patients manage obesity and related conditions, today announced outcomes from its Clinical Obesity Management Program, which demonstrate that most patients do not require expensive GLP-1s to achieve sustainable, significant weight loss. Data from more than 18,000 participants demonstrates that Vida’s tailored treatment plans and commitment to responsible prescribing deliver better outcomes, lower costs, and immediate ROI for health plans and employers.

As employers face growing challenges in addressing obesity and its related conditions, the Midwest Health Purchasers Collaborative (MHPC), a non-profit employer purchasing organization and arm of the Midwest Business Group on Health, has partnered with Vida Health, a virtual obesity and metabolic center of excellence, to provide employers with cost-effective specialty care that manages GLP-1 spending and delivers results.

OptiMed Health Partners, has named Vida Health, a leader in virtual cardiometabolic care, as a preferred partner for providing personalized virtual cardiometabolic care. Through this partnership, Vida Health will provide its full suite of services for members living with obesity, diabetes, and related conditions. Vida will provide managed access to anti-obesity medication to OptiMed clients as well as behavior change coaching to their eligible members.

Vida Health, a leading virtual cardiometabolic clinic is excited to announce a new collaboration with OUTRIGGER Resorts & Hotels, one of the world’s premier beach resort companies. This alliance aims to enrich OUTRIGGER’s employee benefits program by integrating Vida Health’s personalized diabetes management solutions, tailored specifically to meet the unique needs of each of OUTRIGGER’s employees living with diabetes.

Vida Health, a leading virtual cardiometabolic clinic, is proud to announce encouraging preliminary results from its innovative virtual obesity solution with integrated prescribing capabilities. Preliminary data from the initial 1,500 participants enrolled in early 2024 show that fewer than 10% of individuals require GLP-1 (glucagon-like peptide-1) receptor agonists, underscoring the effectiveness of the program's emphasis on behavior change and alternative anti-obesity medications.

Virtual cardiometabolic care leader Vida Health announced the addition of Ravi Guha to its executive leadership team as Chief Financial Officer.

Vida Health (“Vida” or “the Company”), a leading provider of virtual cardiometabolic care services, today announced it has closed $28.5 million in financing led by existing investors, including General Atlantic, Ally Bridge, Canvas Ventures, Hercules Capital, and other insiders. The Company also announced the appointment of Joe Murad as Chief Executive Officer, effective immediately. Murad succeeds Stephanie Tilenius, who will step down following nine years of service as Founder and Chief Executive Officer and will transition to an advisory capacity. Murad has also joined the Company’s Board of Directors.

Vida Health announced its expansion into Spanish-language medical prescribing services for treating physical and mental health conditions together, solidifying Vida’s position as a leader in comprehensive cardiometabolic virtual care and its commitment to equitable care.

New research presented at the American Diabetes Association's 83rd Scientific Sessions showed that Vida Health's virtual cardiometabolic program significantly lowered A1C levels in low-income Medicare Advantage members, even in areas with limited income and food access.

Virtual cardiometabolic care leader Vida Health announced the addition of renowned obesity care expert Fatima Cody Stanford MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS to its Clinical Advisory Council.

Vida Health is expanding its solution for chronic conditions by adding the ability to prescribe and deprescribe glucagon-like peptide 1 (GLP-1) agonists for both type 2 diabetes and obesity for appropriate patients. As part of Vida’s value-oriented treatments for cardiometabolic conditions, patients with obesity and diabetes will now be candidates for GLP-1 therapy within the Vida platform.

In one of the largest studies of participants enrolled in a digital health diabetes management program, Vida Health’s article, published in JMIR Formative Research, demonstrated dramatic improvements in glycemic control and an important relationship between improved management of depression and diabetes.

Virtual cardiometabolic care leader Vida Health today announced the additions of Elaine Divelbliss and Andrew Webb to its executive leadership team. Divelbliss as Chief People Officer & General Counsel and Webb as Chief Financial Officer.

New research published in JMIR Formative Research shows clinically significant Hemoglobin A1C (HbA1C) reduction for a diabetic population who used Vida Health’s Spanish solution. These clinical outcomes reinforce the importance of providing accessible care that’s adapted to fit the needs of diverse populations.

Vida Health today announced the promotion of Richard Frank, MD to Chief Medical Officer. Dr. Frank joined Vida in January of 2022 as SVP of Medical Affairs where he supported the company’s health plan strategy, health economics, and outcomes research strategy. In his new role, Dr. Frank will oversee Vida's clinical research, medical cost saving strategy, and clinical partner collaboration. He’ll also lead Vida’s team of providers who range from registered dietitians and diabetes educators to licensed therapists and certified health coaches.

Vida Health, a leader in virtual cardiometabolic healthcare, is hiring a team of endocrinologists as it continues to expand towards higher acuity treatments. The endocrinologists join Vida in a year when the company has added prescribing capabilities and a Musculoskeletal (MSK) Pain Relief program to its comprehensive virtual solution, and hired a new Chief Medical Officer, Dr. Patrick Carroll.

Vida Health, a leader in cardiometabolic virtual healthcare, now offers Musculoskeletal (MSK) Pain Relief as part of its comprehensive virtual solution. The evidence-based, personalized program was designed by in-house doctors of physical therapy and addresses subacute and chronic lower back pain, one of the most common MSK conditions, affecting 1 in 4 US employees.

New research published in JMIR Formative Research shows 3x greater weight loss among those who also reduced their depressive symptoms compared to those who focused on weight loss alone. The new paper from Vida Health adds to the growing body of peer-reviewed research showing that integrated care for body and mind is the most effective treatment for chronic conditions.

Vida Health announced its expansion into new medical prescribing services for treating physical and mental health conditions together, solidifying its position as a leader in comprehensive cardiometabolic virtual care. Medical prescribing capabilities will enhance the care interventions Vida providers can use to help members with higher-severity conditions see greater health improvements. This service will also help Vida’s business customers achieve greater value and access to broader levels of care when offering virtual chronic care to their populations.

Vida Health, a leader in virtual whole health chronic care, today announced that its founder and CEO Stephanie Tilenius will be participating at William Blair Healthcare Innovators Conference on Tuesday, April 12, 2022.

Vida Health, announced today that Drs. Krysti Lan Chi Vo and Richard Frank have joined the organization as VP, Head of Psychiatry, and SVP of Medical Affairs, respectively. The additions boost Vida’s clinical team as it doubles down on providing value-based care to its members and clients.

Virtual chronic care company Vida Health today announced the hiring of Patrick Carroll, MD as Chief Medical Officer. Dr. Carroll, who joined Vida from Hims & Hers — where he also acted as Chief Medical Officer — will lead Vida’s clinical strategy and protocols, research, clinical partner collaboration, and medical cost saving strategy. Dr. Carroll will also oversee Vida’s team of more than 1,000 providers who range from registered dietitians and diabetes educators to licensed therapists and certified mental health coaches.

Vida Health, a leader in virtual chronic care, announced new additions to its board of directors with veteran Silicon Valley executive George "Skip" Battle and Harlan Levine, MD, President at City of Hope, and a former Chief Clinical Officer of Optum/UnitedHealth Group and EVP of Anthem Inc.

Virtual chronic care platform Vida Health announced today that Validation Institute has validated Vida’s virtually delivered diabetes management program and service for reducing users blood glucose level by a meaningful amount and providing cost savings for payers.

Virtual chronic care company Vida Health, today announced it’s joining Blue Cross and Blue Shield of Illinois’ network of providers to deliver Vida’s best-in-class, on-demand virtual mental health solution to millions of lives in the state.

Virtual care platform Vida Health today announced it has joined the Virgin Pulse partner network, making its licensed coaching and therapy solution available to the millions of employees and health plan members who rely on the Virgin Pulse platform for their health and wellbeing needs.

Virtual chronic care company Vida Health today announced the hiring of Jason Parrott as Senior VP of Enterprise Growth and Partnerships. Parrott, who is joining Vida from Boeing — a Vida client — will lead strategic partnerships.

New research published in the Journal of Medical Internet Research Diabetes (JMIR Diabetes) shows clinically meaningful reductions in Hemoglobin A1c (HbA1c) levels for participants enrolled in Vida Health’s virtual diabetes management program. The study’s findings suggest that Vida’s program represents an accessible, scalable, and effective solution to type 2 diabetes management and improved HbA1c.

Virtual chronic care platform Vida Health announced today that Validation Institute, a service organization that independently verifies performance claims by healthcare vendors, has validated Vida’s virtually delivered therapy program for demonstrating health improvement and cost savings.

Virtual chronic care platform Vida Health announced today that it raised $110M in its Series D funding round led by General Atlantic and joined by Centene, AXA Venture Partners (AVP), and Ardea Capital Partners. Returning investors include Ally Bridge Group, Yahoo founder Jerry Yang’s AME Cloud Ventures, Aspect Ventures, Canvas Ventures, Guidewell, NGP Capital, and Workday Ventures.